A detailed history of California State Teachers Retirement System transactions in Merus N.V. stock. As of the latest transaction made, California State Teachers Retirement System holds 38,277 shares of MRUS stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,277
Previous 35,950 6.47%
Holding current value
$1.64 Million
Previous $2.13 Million 10.11%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$47.19 - $58.84 $109,811 - $136,920
2,327 Added 6.47%
38,277 $1.91 Million
Q2 2024

Aug 14, 2024

BUY
$39.81 - $60.2 $87,781 - $132,741
2,205 Added 6.53%
35,950 $2.13 Million
Q1 2024

May 15, 2024

BUY
$28.03 - $51.82 $26,236 - $48,503
936 Added 2.85%
33,745 $1.52 Million
Q4 2023

Feb 13, 2024

SELL
$20.06 - $28.66 $95,465 - $136,392
-4,759 Reduced 12.67%
32,809 $902,000
Q3 2023

Nov 14, 2023

BUY
$20.13 - $27.29 $223,080 - $302,427
11,082 Added 41.84%
37,568 $885,000
Q2 2023

Aug 21, 2023

BUY
$18.33 - $27.18 $843 - $1,250
46 Added 0.17%
26,486 $697,000
Q1 2023

May 09, 2023

BUY
$14.25 - $20.5 $7,680 - $11,049
539 Added 2.08%
26,440 $486,000
Q4 2022

Feb 14, 2023

BUY
$12.8 - $23.66 $19,776 - $36,554
1,545 Added 6.34%
25,901 $400,000
Q3 2022

Nov 18, 2022

BUY
$18.64 - $28.93 $14,446 - $22,420
775 Added 3.29%
24,356 $488,000
Q2 2022

Aug 15, 2022

SELL
$13.98 - $29.25 $1,901 - $3,978
-136 Reduced 0.57%
23,581 $534,000
Q1 2022

May 16, 2022

BUY
$23.58 - $30.91 $6,956 - $9,118
295 Added 1.26%
23,717 $627,000
Q4 2021

Feb 15, 2022

BUY
$20.0 - $32.29 $117,020 - $188,928
5,851 Added 33.3%
23,422 $745,000
Q3 2021

Nov 15, 2021

BUY
$16.48 - $27.23 $289,570 - $478,458
17,571 New
17,571 $387,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.96B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.